Quintrio
Home

BLANK CHECKS

Amanat Acquisition Corp Class A Ordinary Shares

AMAN

Amanat Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Last trade $10.10
Day change -$0.005 (-0.05%)
Day range $10.08 – $10.13
Volume 114,169
Market cap $98M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for AMAN.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for AMAN.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Corxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Company

Corxel US, a clinical-stage biopharmaceutical company, has announced a definitive business combination agreement with Amanat Acquisition Corp (Nasdaq: AMAN) to become a publicly traded obesity-focused company. The transaction is expected to provide approximately $377 million in gross proceeds, with $300 million from a PIPE financing backed by prominent healthcare investors. The combined company will advance CX11, a once-daily oral GLP-1 receptor agonist that demonstrated clinically meaningful weight loss in Phase 2 trials, and CX12, an oral amylin receptor agonist. The transaction is expected to close in the first half of 2027.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.